Magnetic resonance imaging findings in adult-form myotonic dystrophy type 1

被引：1

作者：

Jakkani, Ravikanth ^{[1
]}

Jyoti, Sureka ^{[1
]}

Ahmed, Munawwar ^{[1
]}

Thomas, Maya Mary ^{[2
]}

机构：

[1] Christian Med Coll & Hosp, Dept Radiol, Vellore, Tamil Nadu, India

[2] Christian Med Coll & Hosp, Dept Neurol, Vellore, Tamil Nadu, India

来源：

SINGAPORE MEDICAL JOURNAL | 2012年 / 53卷 / 07期

关键词：

adult form; congenital; magnetic resonance imaging; myotonic dystrophy; WHITE-MATTER ABNORMALITIES; CENTRAL-NERVOUS-SYSTEM; PATTERN;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The adult form of myotonic dystrophy type 1 is a neuromuscular disorder with multisystem involvement, including the central nervous system (CNS). The presenting clinical features of this condition include distal muscle weakness, myotonia, intellectual decline, cataract, frontal baldness and testicular atrophy. Magnetic resonance (MR) imaging shows characteristic white matter changes in the CNS. The clinical presentation, characteristic white matter changes in the brain on MR imaging and electromyographic findings aid in the diagnosis of this disorder.

引用

页码：E150 / E152

页数：3

共 50 条

[41] Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study [J].

Edyta Blaszczyk ;

Carolin Lim ;

Peter Kellman ;

Luisa Schmacht ;

Jan Gröschel ;

Simone Spuler ;

Jeanette Schulz-Menger .

Journal of Cardiovascular Magnetic Resonance, 23

[42] A patient with neurofibromatosis type 1 and myotonic dystrophy type 1 [J].

Esra, Serdaroglu ;

Ceren, Gunbey ;

Banu, Anlar .

NEUROLOGY ASIA, 2022, 27 (02) :503-506

[43] Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study [J].

Blaszczyk, Edyta ;

Lim, Carolin ;

Kellman, Peter ;

Schmacht, Luisa ;

Groschel, Jan ;

Spuler, Simone ;

Schulz-Menger, Jeanette .

JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2021, 23 (01)

[44] Myotonic Dystrophy Type 1 Management and Therapeutics [J].

Cheryl A. Smith ;

Laurie Gutmann .

Current Treatment Options in Neurology, 2016, 18

[45] Diffusion Tensor Imaging Shows Differences Between Myotonic Dystrophy Type 1 and Type 2 [J].

Rehmann, R. ;

Schneider-Gold, C. ;

Froeling, M. ;

Guettsches, A. K. ;

Rohm, M. ;

Forsting, J. ;

Vorgerd, M. ;

Schlaffke, L. .

JOURNAL OF NEUROMUSCULAR DISEASES, 2021, 8 (06) :949-962

[46] Pathogenesis of myotonic dystrophy type 1. [J].

Magana, Jonathan J. ;

Leyva-Garcia, Norberto ;

Cisneros, Bulmaro .

GACETA MEDICA DE MEXICO, 2009, 145 (04) :331-337

[47] Multiorgan manifestations in myotonic dystrophy type 1 [J].

Varga David ;

Pal Endre .

ORVOSI HETILAP, 2019, 160 (37) :1447-1454

[48] Targeting Myotonic Dystrophy Type 1 with Metformin [J].

Garcia-Puga, Mikel ;

Saenz-Antonanzas, Ander ;

Matheu, Ander ;

Lopez de Munain, Adolfo .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)

[49] Life habits in myotonic dystrophy type 1 [J].

Gagnon, Cynthia ;

Mathieu, Jean ;

Noreau, Luc .

JOURNAL OF REHABILITATION MEDICINE, 2007, 39 (07) :560-566

[50] Cardiac Pathology in Myotonic Dystrophy Type 1 [J].

Mahadevan, Mani S. ;

Yadava, Ramesh S. ;

Mandal, Mahua .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)

← 1 2 3 4 5 →